XINTHERA Trademark

Trademark Overview


On Friday, June 18, 2021, a trademark application was filed for XINTHERA with the United States Patent and Trademark Office. The USPTO has given the XINTHERA trademark a serial number of 90782159. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, January 25, 2024. This trademark is owned by Xinthera, Inc.. The XINTHERA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Therapeutic pharmaceuticals for the treatment of cancer, inflammation and autoimmune diseases; pharmaceutical products for the prevention and treatment of cancer, inflammation and autoimmune diseases; anti-cancer preparations; small molecule therapies for the treatment of cancer, namely, therapeutic agents that treat cancer

Licensing of intellectual property

Scientific research for medical purposes in the field of oncology, inflammation and autoimmune diseases; research and development of therapeutics for the treatment of cancer, inflammation and autoimmune diseases; research and development in the field of small molecule therapeutics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development
xinthera

General Information


Serial Number90782159
Word MarkXINTHERA
Filing DateFriday, June 18, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, January 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements


Goods and ServicesTherapeutic pharmaceuticals for the treatment of cancer, inflammation and autoimmune diseases; pharmaceutical products for the prevention and treatment of cancer, inflammation and autoimmune diseases; anti-cancer preparations; small molecule therapies for the treatment of cancer, namely, therapeutic agents that treat cancer
Goods and ServicesLicensing of intellectual property
Goods and ServicesScientific research for medical purposes in the field of oncology, inflammation and autoimmune diseases; research and development of therapeutics for the treatment of cancer, inflammation and autoimmune diseases; research and development in the field of small molecule therapeutics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 3, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 3, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 3, 2021
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXinthera, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameXinthera, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Saturday, January 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2024SOU EXTENSION 3 GRANTED
Thursday, January 25, 2024SOU EXTENSION 3 FILED
Thursday, January 25, 2024SOU TEAS EXTENSION RECEIVED
Saturday, July 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 20, 2023SOU EXTENSION 2 GRANTED
Thursday, July 20, 2023SOU EXTENSION 2 FILED
Thursday, July 20, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 14, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 14, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, February 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 2, 2023SOU EXTENSION 1 GRANTED
Thursday, February 2, 2023SOU EXTENSION 1 FILED
Thursday, February 2, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 17, 2022NON-FINAL ACTION E-MAILED
Thursday, March 17, 2022NON-FINAL ACTION WRITTEN
Thursday, March 10, 2022ASSIGNED TO EXAMINER
Friday, September 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 22, 2021NEW APPLICATION ENTERED